Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2012, Article ID 636392, 5 pages
http://dx.doi.org/10.1155/2012/636392
Research Article

Increased -Fetoprotein Predicts Steatosis among Patients with Chronic Hepatitis C Genotype 4

1Department of Tropical Medicine, Mansoura University, Mansoura 35516, Egypt
2Department of Internal Medicine, Mansoura University, Mansoura 35516, Egypt
3Department of Pathology, Mansoura University, Mansoura 35516, Egypt
4Department of Clinical Pathology, Mansoura University, Mansoura 35516, Egypt

Received 1 December 2011; Revised 3 February 2012; Accepted 11 March 2012

Academic Editor: Guruprasad P. Aithal

Copyright © 2012 Nasser Mousa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. A. Harrison, “Steatosis and chronic hepatitis C infection: mechanisms and significance,” Clinical Gastroenterology and Hepatology, vol. 3, supplement 2, pp. S92–S96, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Lonardo, L. E. Adinolfi, P. Loria, N. Carulli, G. Ruggiero, and C. P. Day, “Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease,” Gastroenterology, vol. 126, no. 2, pp. 586–597, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Castera, P. Chouteau, C. Hezode, E. S. Zafrani, D. Dhumeaux, and J. M. Pawlotsky, “Hepatitis C virus-induced hepatocellular steatosis,” American Journal of Gastroenterology, vol. 100, no. 3, pp. 711–715, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Halbrecht and C. Klibanski, “Identification of a new normal embryonic hæmoglobin,” Nature, vol. 178, no. 4537, pp. 794–795, 1956. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Gupta, S. Bent, and J. Kohlwes, “Test characteristics of α-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C: a systematic review and critical analysis,” Annals of Internal Medicine, vol. 139, no. 1, pp. 46–50, 2003. View at Google Scholar · View at Scopus
  6. F. C. Brunicardi, Ed., Schwartz's Principles of Surgery, McGraw-Hill, 8th edition, 2004.
  7. C. H. Chen, S. T. Lin, C. L. Kuo, and C. K. Nien, “Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma,” Hepato-Gastroenterology, vol. 55, no. 85, pp. 1423–1427, 2008. View at Google Scholar · View at Scopus
  8. N. S. Goldstein, D. E. Blue, R. Hankin et al., “Serum α-fetoprotein levels in patients with chronic hepatitis C: relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores,” American Journal of Clinical Pathology, vol. 111, no. 6, pp. 811–816, 1999. View at Google Scholar · View at Scopus
  9. S. C. Ray, R. R. Arthur, A. Carella, J. Bukh, and D. L. Thomas, “Genetic epidemiology of hepatitis C virus throughout Egypt,” Journal of Infectious Diseases, vol. 182, no. 3, pp. 698–707, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. D. E. Kleiner, E. M. Brunt, M. van Natta et al., “Design and validation of a histological scoring system for nonalcoholic fatty liver disease,” Hepatology, vol. 41, no. 6, pp. 1313–1321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Ishak, A. Baptista, L. Bianchi et al., “Histological grading and staging of chronic hepatitis,” Journal of Hepatology, vol. 22, no. 6, pp. 696–699, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. “National Institutes of Health consensus development conference statement: management of hepatitis C,” Hepatology, vol. 36, no. 5, supplement 1, pp. s3–s20, 2002.
  13. M. J. Alter, “Epidemiology of hepatitis C in the west,” Seminars in Liver Disease, vol. 15, no. 1, pp. 5–14, 1995. View at Google Scholar · View at Scopus
  14. J. M. Micallef, J. M. Kaldor, and G. J. Dore, “Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies,” Journal of Viral Hepatitis, vol. 13, no. 1, pp. 34–41, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Levrero, “Viral hepatitis and liver cancer: the case of hepatitis C,” Oncogene, vol. 25, no. 27, pp. 3834–3847, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Asselah, L. Rubbia-Brandt, P. Marcellin, and F. Negro, “Steatosis in chronic hepatitis C: why does it really matter?” Gut, vol. 55, no. 1, pp. 123–130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. C. Thomopoulos, V. Arvaniti, A. C. Tsamantas et al., “Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis,” European Journal of Gastroenterology and Hepatology, vol. 18, no. 3, pp. 233–237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Rubbia-Brandt, P. Fabris, S. Paganin et al., “Steatosis affects chronic hepatitis C progression in a genotype specific way,” Gut, vol. 53, no. 3, pp. 406–412, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. L. E. Adinolfi, M. Gambardella, A. Andreana, M. F. Tripodi, R. Utili, and G. Ruggiero, “Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity,” Hepatology, vol. 33, no. 6, pp. 1358–1364, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Hui, J. Kench, G. C. Farrell et al., “Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection,” Journal of Gastroenterology and Hepatology, vol. 17, no. 8, pp. 873–881, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Collier and M. Sherman, “Screening for hepatocellular carcinoma,” Hepatology, vol. 27, no. 1, pp. 273–278, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. L. F. Hourigan, G. A. Macdonald, D. Purdie et al., “Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis,” Hepatology, vol. 29, no. 4, pp. 1215–1219, 1999. View at Google Scholar · View at Scopus
  23. L. E. Adinolfi, M. Gambardella, A. Andreana, M. F. Tripodi, R. Utili, and G. Ruggiero, “Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity,” Hepatology, vol. 33, no. 6, pp. 1358–1364, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Cai, M. Yuan, D. F. Frantz et al., “Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB,” Nature Medicine, vol. 11, no. 2, pp. 183–190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. M. C. Arkan, A. L. Hevener, F. R. Greten et al., “IKK-β links inflammation to obesity-induced insulin resistance,” Nature Medicine, vol. 11, no. 2, pp. 191–198, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Okuda, K. Li, M. R. Beard et al., “Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein,” Gastroenterology, vol. 122, no. 2, pp. 366–375, 2002. View at Google Scholar · View at Scopus
  27. L. Germain, M. Noel, H. Gourdeau, and N. Marceau, “Promotion of growth and differentiation of rat ductular oval cells in primary culture,” Cancer Research, vol. 48, no. 2, pp. 368–378, 1988. View at Google Scholar · View at Scopus
  28. N. Shiojiri, J. M. Lemire, and N. Fausto, “Cell lineages and oval cell progenitors in rat liver development,” Cancer Research, vol. 51, no. 10, pp. 2611–2620, 1991. View at Google Scholar · View at Scopus
  29. M. D. Dabeva and D. A. Shafritz, “Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of liver regeneration,” American Journal of Pathology, vol. 143, no. 6, pp. 1606–1620, 1993. View at Google Scholar · View at Scopus
  30. A. C. Tsamandas, I. Syrokosta, K. Thomopoulos et al., “Potential role of hepatic progenitor cells expression in cases of chronic hepatitis C and their relation to response to therapy: a clinicopathologic study,” Liver International, vol. 26, no. 7, pp. 817–826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Yin, D. Lynch, Z. Ilic, and S. Sell, “Proliferation and differentiation of ductular progenitor cells and littoral cells during the regeneration of the rat liver to CCl4/2-AAF injury,” Histology and Histopathology, vol. 17, no. 1, pp. 65–81, 2002. View at Google Scholar · View at Scopus
  32. A. D. Clouston, E. E. Powell, M. J. Walsh, M. M. Richardson, A. J. Demetris, and J. R. Jonsson, “Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis,” Hepatology, vol. 41, no. 4, pp. 809–818, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Chopra and P. H. Griffin, “Laboratory tests and diagnostic procedures in evaluation of liver disease,” American Journal of Medicine, vol. 79, no. 2, pp. 221–230, 1985. View at Google Scholar · View at Scopus
  34. M. J. Hepburn, J. A. Vos, E. P. Fillman, and E. J. Lawitz, “The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study,” BMC Gastroenterology, vol. 5, article 14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. C. W. Chu, S. J. Hwang, J. C. Luo et al., “Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C,” Journal of Clinical Gastroenterology, vol. 32, no. 3, pp. 240–244, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Q. Hu, N. L. Kyulo, N. Lim, B. Elhazin, D. J. Hillebrand, and T. Bock, “Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma,” American Journal of Gastroenterology, vol. 99, no. 5, pp. 860–865, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Nakata, M. Motomura, H. Nakabayashi, A. Ido, and T. Tamaoki, “A possible mechanism of inverse developmental regulation of α-fetoprotein and albumin genes,” The Journal of Biological Chemistry, vol. 267, no. 2, pp. 1331–1334, 1992. View at Google Scholar · View at Scopus
  38. Y. Niwa, M. Matsumura, Y. Shiratori et al., “Quantitation of α-fetoprotein and albumin messenger RNAs in human hepatocellular carcinoma,” Hepatology, vol. 23, no. 6, pp. 1384–1392, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Panduro, F. Shalaby, F. R. Weiner, L. Biempica, M. A. Zern, and D. A. Shafritz, “Transcriptional switch from albumin to α-fetoprotein and changes in transcription of other genes during carbon tetrachloride induced liver regeneration,” Biochemistry, vol. 25, no. 6, pp. 1414–1420, 1986. View at Google Scholar · View at Scopus
  40. N. Bayati, A. L. Silverman, and S. C. Gordon, “Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C,” American Journal of Gastroenterology, vol. 93, no. 12, pp. 2452–2456, 1998. View at Publisher · View at Google Scholar · View at Scopus